Targeted delivery of ifn gamma using antibody fusion proteins
AssigneeThe Regents of the University of California
InventorsKham M. Trinh, John Matthew Timmerman, Sherie Leaver Morrison
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsKham M. Trinh, John Matthew Timmerman, Sherie Leaver Morrison
Estimating the term…
In various embodiments targeted interferon constructs are provided. In certain embodiments the constructs comprise a full-length immunoglobulin or a camelid antibody attached to an interferon gamma (IFNγ) where said immunoglobulin or camelid antibody is an antibody that binds to a tumor associated antigen; a first interferon gamma (IFNγ) is attached to a first constant heavy region 3 (CH3) of the immunoglobulin or camelid antibody by a first proteolysis resistant peptide linker; a second interferon gamma is attached to a second constant heavy region 3 (CH3) of the immunoglobulin or camelid antibody by a second proteolysis resistant peptide linker; and the first proteolysis resistant linker and the second proteolysis linker have a length and flexibility that permits said first interferon gamma and said second interferon gamma to dimerize.
A chimeric construct comprising a full-length immunoglobulin or a camelid antibody attached to an interferon gamma (IFNγ) wherein:
Dependencies are inferred from the claim text.